Literature DB >> 16580443

Decellularized heart valve as a scaffold for in vivo recellularization: deleterious effects of granulocyte colony-stimulating factor.

Francis Juthier1, André Vincentelli, Julien Gaudric, Delphine Corseaux, Olivier Fouquet, Christine Calet, Thierry Le Tourneau, Valérie Soenen, Christophe Zawadzki, Olivier Fabre, Sophie Susen, Alain Prat, Brigitte Jude.   

Abstract

BACKGROUND: Autologous recellularization of decellularized heart valve scaffolds is a promising challenge in the field of tissue-engineered heart valves and could be boosted by bone marrow progenitor cell mobilization. The aim of this study was to examine the spontaneous in vivo recolonization potential of xenogeneic decellularized heart valves in a lamb model and the effects of granulocyte colony-stimulating factor mobilization of bone marrow cells on this process.
METHODS: Decellularized porcine aortic valves were implanted in 12 lambs. Six lambs received granulocyte colony-stimulating factor (10 microg x kg(-1) x d(-1) for 7 days, granulocyte colony-stimulating factor group), and 6 received no granulocyte colony-stimulating factor (control group). Additionally, nondecellularized porcine valves were implanted in 5 lambs (xenograft group). Angiographic and histologic evaluation was performed at 3, 6, 8, and 16 weeks.
RESULTS: Few macroscopic modifications of leaflets and the aortic wall were observed in the control group, whereas progressive shrinkage and thickening of the leaflets appeared in the granulocyte colony-stimulating factor and xenograft groups. In the 3 groups progressive ovine cell infiltration (fluorescence in situ hybridization) was observed in the leaflets and in the adventitia and the intima of the aortic wall but not in the media. Neointimal proliferation of alpha-actin-positive cells, inflammatory infiltration, adventitial neovascularization, and calcifications were more important in the xenograft and the granulocyte colony-stimulating factor groups than in the control group. Continuous re-endothelialization appeared only in the control group.
CONCLUSION: Decellularized xenogeneic heart valve scaffolds allowed partial autologous recellularization. Granulocyte colony-stimulating factor led to accelerated heart valve deterioration similar to that observed in nondecellularized xenogeneic cardiac bioprostheses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16580443     DOI: 10.1016/j.jtcvs.2005.11.037

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  11 in total

Review 1.  Immunogenicity in xenogeneic scaffold generation: antigen removal vs. decellularization.

Authors:  Maelene L Wong; Leigh G Griffiths
Journal:  Acta Biomater       Date:  2014-01-31       Impact factor: 8.947

2.  Preparation of decellularized and crosslinked artery patch for vascular tissue-engineering application.

Authors:  Yilin Zhao; Zhigang Zhang; Jinling Wang; Ping Yin; Yu Wang; Zhenyu Yin; Jianyin Zhou; Gang Xu; Yun Liu; Zhigang Deng; Maochuan Zhen; Wugeng Cui; Zhongchen Liu
Journal:  J Mater Sci Mater Med       Date:  2011-04-28       Impact factor: 3.896

3.  CD34 affinity pheresis attenuates a surge among circulating progenitor cells following vascular injury.

Authors:  Adriana Harbuzariu; Justine Kim; E Michael Meyer; Albert D Donnenberg; Bryan W Tillman
Journal:  J Vasc Surg       Date:  2013-07-19       Impact factor: 4.268

4.  Synergistic effect of fibronectin and hepatocyte growth factor on stable cell-matrix adhesion, re-endothelialization, and reconstitution in developing tissue-engineered heart valves.

Authors:  Sheng-Dong Huang; Xiao-Hong Liu; Chen-Guang Bai; Fang-Lin Lu; Yang Yuan; De-Jun Gong; Zhi-Yun Xu
Journal:  Heart Vessels       Date:  2007-03-23       Impact factor: 1.814

Review 5.  Tissue engineered scaffolds for an effective healing and regeneration: reviewing orthotopic studies.

Authors:  Silvia Baiguera; Luca Urbani; Costantino Del Gaudio
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

6.  Supercritical carbon dioxide-based sterilization of decellularized heart valves.

Authors:  Ryan S Hennessy; Soumen Jana; Brandon J Tefft; Meghana R Helder; Melissa D Young; Rebecca R Hennessy; Nicholas J Stoyles; Amir Lerman
Journal:  JACC Basic Transl Sci       Date:  2017-02

7.  Human Mesenchymal Stem Cells Reendothelialize Porcine Heart Valve Scaffolds: Novel Perspectives in Heart Valve Tissue Engineering.

Authors:  Paola Lanuti; Francesco Serafini; Laura Pierdomenico; Pasquale Simeone; Giuseppina Bologna; Eva Ercolino; Sara Di Silvestre; Simone Guarnieri; Carlo Canosa; Gianna Gabriella Impicciatore; Stella Chiarini; Francesco Magnacca; Maria Addolorata Mariggiò; Assunta Pandolfi; Marco Marchisio; Gabriele Di Giammarco; Sebastiano Miscia
Journal:  Biores Open Access       Date:  2015-06-01

8.  Cryopreserved CD90+ cells obtained from mobilized peripheral blood in sheep: a new source of mesenchymal stem cells for preclinical applications.

Authors:  Carlos Landa-Solís; Julio Granados-Montiel; Anell Olivos-Meza; Carmina Ortega-Sánchez; Mónica Cruz-Lemini; Cecilia Hernández-Flores; María Eugenia Chang-González; Ricardo Gómez García; Brenda Olivos-Díaz; María Cristina Velasquillo-Martínez; Carlos Pineda; Clemente Ibarra
Journal:  Cell Tissue Bank       Date:  2015-07-29       Impact factor: 1.522

Review 9.  Recellularization of decellularized heart valves: Progress toward the tissue-engineered heart valve.

Authors:  Mitchell C VeDepo; Michael S Detamore; Richard A Hopkins; Gabriel L Converse
Journal:  J Tissue Eng       Date:  2017-08-25       Impact factor: 7.813

10.  Can We Grow Valves Inside the Heart? Perspective on Material-based In Situ Heart Valve Tissue Engineering.

Authors:  Carlijn V C Bouten; Anthal I P M Smits; Frank P T Baaijens
Journal:  Front Cardiovasc Med       Date:  2018-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.